Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3696]

Immunotherapy could work against bowel cancers resistant to important targeted treatment

Immunotherapy could work against bowel cancers resistant to important targeted treatment

Two-in-one drug combining trastuzumab with chemotherapy keeps women’s breast cancers at bay

Two-in-one drug combining trastuzumab with chemotherapy keeps women’s breast cancers at bay

FDA grants accelerated approval to selinexor for multiple myeloma

FDA grants accelerated approval to selinexor for multiple myeloma

Exercise improves anxiety and mood in older adults undergoing chemotherapy

Exercise improves anxiety and mood in older adults undergoing chemotherapy

Bacteria engineered as Trojan horse for cancer immunotherapy

Bacteria engineered as Trojan horse for cancer immunotherapy

Immune-boosting compound makes immunotherapy effective against pancreatic cancer

Immune-boosting compound makes immunotherapy effective against pancreatic cancer

High doses of 60 plus-year-old chemotherapy drug found to spur immune system attack on lymphoma

High doses of 60 plus-year-old chemotherapy drug found to spur immune system attack on lymphoma

New study showing drug prolongs life for patients with ovarian cancer

New study showing drug prolongs life for patients with ovarian cancer

New hope for aggressive breast cancers as diabetes drug creates treatment ‘sweet spot’

New hope for aggressive breast cancers as diabetes drug creates treatment ‘sweet spot’

$EHA 2019: Acalabrutinib shows remarkable benefit in relapsed or refractory chronic lymphocytic leukaemia$

EHA 2019: Acalabrutinib shows remarkable benefit in relapsed or refractory chronic lymphocytic leukaemia

More from ecancer